Identification and molecular characterization of human T lymphotropic virus type II infections in intravenous drug abusers in the former South Vietnam

AIDS Research and Human Retroviruses

Volumn 14, Issue 6, 1998, Pages 537-540

  Fukushima, Yoshiko ^a,b   Lewis, Martha J ^a,c   Monken, Claude ^d   Komuro, Katsutoshi ^b   Kusagawa, Shigeru ^b   Sato, Hironori ^b   Takebe, Yutaka ^b   Yamazaki, Shudo ^b   Hien, Nguyen Tran ^e   Anh, Hoang ^f   Long, Hoang Thuy ^e   Honda, Mitsuo ^b   Hall, William W ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c ROCKEFELLER UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^f An Giang Province Medicine Preventive Center   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; VIET NAM; VIRUS CHARACTERIZATION;

EID: 0032502696     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.537     Document Type: Article

References (26)

1. Takatsuki K, Hinuma Y, and Yoshida M: "Advances in Adult T-Cell Leukemia and UTLV-I Research." Gann Monograph on Cancer Research 39. Japanese Scientific Society, Tokyo, Japan, 1992.
2. Hollsberg P and Hafler DA: Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993;328: 1173-1182.
3. Hall WW, Kubo T, Ijichi S, Takahashi T, and Zhu SW: Human T cell leukemia/lymphoma vitus, type II (HTLV-II): Emergence of an important newly recognize pathogen. Semin Virol 1994; 5:165-178.
4. Hall WW, Ishak R, Zhu SW, Novoa P, Eiraku N, Takahashi H, de Costa Ferreira M, Azevedo V, Ishak MO, de Costa Ferreira O, Monken C, and Kurata T: Human T lymphotropic virus type II (HTLV-II): Epidemiology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S204-S214.
5. Fukushima Y, Nakasone T, Nakata S, Pham S, Dao DD, Komuro K, and Honda M: Human T-lymphotropic virus type-II in Vietnam. Lancet 1994;344:485.
6. Fukushima Y, Takahashi H, Hall WW, Nakasone T, Nakata S, Song P, Duc DD, Hien B, Quang NX, Trinh TN, Nishioka K, Kitamura K, Komuro K, Vahlne A, and Honda M: Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam. AIDS Res Hum Retroviruses 1995;11:637-644.
7. Switzer WM, Pieniazek D, Swanson P, Samdal HH, Soriano V, Khabbaz RF, Kaplan JE, Lal RB, and Heneine W: Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995;69:621-632.
8. Eiraku N, Monken C, Kubo T, Zhu SW, Rios M, Bianco C, Hjelle B, Nagashima K, and Hall WW: Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS Res Hum Retroviruses 1995;11:625-636.
9. Hall WW, Takahashi H, Lui C, Kaplan MH, Scheewind O, Ijichi S, Nagashima K, and Gallo RC: Multiple isolate and characteristics of human T-cell leukemia virus type II. J Virol 1992; 66:2456-2463.
10. Takahashi H, Zhu SW, Ijichi S, Vahlne A, Suzuki H, and Hall WW: Nucleotide sequence analysis of human T cell leukemia virus, type II (HTLV-II) isolates. AIDS Res Hum Retroviruses 1993;9: 721-732.
11. Vallejo A, Ferrante P, Soriano V, Calabro ML, Mancuso R, Heredia A, Mannella E, Favero A, Garcia-Saiz A, Chieco-Bianchi L, Gonzalez-Lahoz J, and Hewlett IK: Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: Evidence for the HTLV-IIa and HTLV-IIb subtypes. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:384-391.
12. Vallejo A and Ferrante P: Nucleotide sequence and RFLP analysis of HTLV-II in southern Europe. Evidence for the HTLV-IIa and HTLV-IIb subtypes. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:384-391.
13. Salemi M, Cattaneo E, Casoli C, and Bertazzoni U: Identification of IIa and IIb molecular subtypes of human T-cell lymphotropic virus type II among Italian injecting drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:516-520.
14. Salemi M, Vandamme AM, Guano F, Gradozzi C, Cattaneo E, Casoli C, and Bertazzoni U: Complete nucleotide sequence of the Italian human T-cell lymphotropic virus type II isolate Gu and phylogenetic identification of a possible origin of south European epidemics. J Gen Virol 1996;77:1193-1201.
15. Zella D, Cavicchini A, Salemi M, Casoli C, Lori F, Achilli G, Cattaneo E, Landini V, and Bertazzoni U: Molecular characterisation of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol 1993;74:437-444.
16. Calabro ML, Luparello M, Grottola A, Del Mistro A, Fiore JR, Angarano G, and Chieco-Bianchi L: Detection of human T lymphotropic virus type IIb in human immunodeficiency virus type I-coinfected persons in south eastern Italy. J Infect Dis 1993;168: 1273-1277.
17. Switzer WM, Pieniazek D, Swanson P, Holm Samdal H, Soriano V, Khabbaz RF, Kaplan JE, Lal RB, and Heneine W: Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995; 69:621-632.
18. Fuchs R: Free molecular biological software available from the EMBL file server. Comput Appl Biosci 1990;6:120-121.
19. Shimotohno K, Takahashi Y, Shimizu N, Gojobori T, Golde DW, Chen IS, Miwa M, and Sugimura T: Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: An open reading frame for the protease gene. Proc Natl Acad Sci USA 1985;82:3101-3105.
20. Lee H, Idler KB, Swanson P, Aparicio JJ, Chin KK, Lax JP, Nguyen M, Mann T, Leckie G, Zanetti A, Marinucci G, Chen IS, and Rosenblatt JD: Complete nucleotide sequence of HTLV-II isolate NRA: Comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian i.v. drug users. Virology 1993;196:57-69.
21. Felsenstein J: PHYLIP (phylogeny inference package), version 3.5c. Distributed by the author. Department of Genetics, University of Washington, Seattle, Washington.
22. Thompson JD, Higgins DG, and Gibson J: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
23. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4: 406-425.
24. Lin MT, Nguyen BT, Binh TV, Be TV, Chiang TY, Tseng LH, Yang YC, Lin KH, and Chen YC: Human T-lymphotropic virus type II infection in Vietnamese thalassemic patients. Arch Virol 1997;142:1429-1440.
25. Biggar RJ, Buskell-Bales Z, Yakshe PN, Caussy D, Gridley G, and Seeff L: Antibody to human retroviruses among drug users in three east coast American cities, 1972-1976. J Infect Dis 1991; 163:57-63.
26. Khabbaz RF, Hartel D, Lairmore M, Horsburgh CR, Schoenbaum EE, Roberts B, Hartley TM, and Friedland G: Human T lymphotropic virus type II (HTLV-II) infections in a cohort of New York intravenous drug users: An old infection? J Infect Dis 1991;163:252-256.